w*m
2 楼
能上2块就不错,这家就是被华尔街蹂躏烂的破鞋
j*x
3 楼
拉回10得涨10倍啊。。。。。。 可能性太小了~~
除了那个aqxp,最近5年还有股票一口气涨十倍吗
除了那个aqxp,最近5年还有股票一口气涨十倍吗
m*h
4 楼
大盘低位盘旋三周,长线选手终于出来了。
l*m
7 楼
http://www.thestreet.com/story/13277174/6/5-stocks-under-10-set
"One final under-$10 biopharmaceutical player that's starting to trend
within range of triggering a big breakout trade is Vivus (VVUS) , which
develops and commercializes therapies to address unmet needs in obesity,
sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
This stock has been hit hard by the bears over the last three months, with
shares down large by 50.2%.
If you take a glance at the chart for Vivus, you'll notice that this stock
has been uptrending strong over the last few weeks, with shares moving
higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a
share. During that uptrend, this stock has been making mostly higher lows
and higher highs, which is bullish technical price action. Shares of Vivus
ripped higher on Wednesday right off its 20-day moving average of $1.13 with
strong upside volume flows. That move is now quickly pushing this stock
within range of triggering a big breakout trade.
"
"One final under-$10 biopharmaceutical player that's starting to trend
within range of triggering a big breakout trade is Vivus (VVUS) , which
develops and commercializes therapies to address unmet needs in obesity,
sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
This stock has been hit hard by the bears over the last three months, with
shares down large by 50.2%.
If you take a glance at the chart for Vivus, you'll notice that this stock
has been uptrending strong over the last few weeks, with shares moving
higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a
share. During that uptrend, this stock has been making mostly higher lows
and higher highs, which is bullish technical price action. Shares of Vivus
ripped higher on Wednesday right off its 20-day moving average of $1.13 with
strong upside volume flows. That move is now quickly pushing this stock
within range of triggering a big breakout trade.
"
l*m
8 楼
Union.
with
a
【在 l*********m 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: http://www.thestreet.com/story/13277174/6/5-stocks-under-10-set
: "One final under-$10 biopharmaceutical player that's starting to trend
: within range of triggering a big breakout trade is Vivus (VVUS) , which
: develops and commercializes therapies to address unmet needs in obesity,
: sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
: This stock has been hit hard by the bears over the last three months, with
: shares down large by 50.2%.
: If you take a glance at the chart for Vivus, you'll notice that this stock
: has been uptrending strong over the last few weeks, with shares moving
: higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a
d*1
9 楼
这个我也读了。。但是最大的concerns是它这个治obesity的药被几个大的phamacy
benefit plans excluded,替代viagra的新药貌似也没钱marketing好,所以你给的
chart才滑坡地那么吓人(°_°)
Union.
with
a
【在 l*********m 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: http://www.thestreet.com/story/13277174/6/5-stocks-under-10-set
: "One final under-$10 biopharmaceutical player that's starting to trend
: within range of triggering a big breakout trade is Vivus (VVUS) , which
: develops and commercializes therapies to address unmet needs in obesity,
: sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
: This stock has been hit hard by the bears over the last three months, with
: shares down large by 50.2%.
: If you take a glance at the chart for Vivus, you'll notice that this stock
: has been uptrending strong over the last few weeks, with shares moving
: higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a
benefit plans excluded,替代viagra的新药貌似也没钱marketing好,所以你给的
chart才滑坡地那么吓人(°_°)
Union.
with
a
【在 l*********m 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: http://www.thestreet.com/story/13277174/6/5-stocks-under-10-set
: "One final under-$10 biopharmaceutical player that's starting to trend
: within range of triggering a big breakout trade is Vivus (VVUS) , which
: develops and commercializes therapies to address unmet needs in obesity,
: sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
: This stock has been hit hard by the bears over the last three months, with
: shares down large by 50.2%.
: If you take a glance at the chart for Vivus, you'll notice that this stock
: has been uptrending strong over the last few weeks, with shares moving
: higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a
C*1
16 楼
这VVUS看起来不错,短线看涨。
相关阅读